Compound for the treatment of tuberculosis

Details for Australian Patent Application No. 2010224619 (hide)

Owner AstraZeneca AB

Inventors Kaveri, Das; Melnick, David Alan; Radha, Shandil

Agent Davies Collison Cave

Pub. Number AU-A-2010224619

PCT Pub. Number WO2010/106355

Priority 61/160,385 16.03.09 US

Filing date 16 March 2010

Wipo publication date 23 September 2010

International Classifications

A61K 31/4439 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 31/06 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

8 September 2011 PCT application entered the National Phase

  PCT publication WO2010/106355 Priority application(s): WO2010/106355

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010224629-Interface module, system and method

2010224615-Dietary supplement